Next, we examined the differences in TAM subpopulation proportions between responders and non-responders in CRC and NSCLC cohorts, indicating a higher proportion of STMN2+ TAM and SPP1+ TAM among non-responders (Figure 3E). This evidence concerns the gene STMN2 and non-small cell lung carcinoma.